Russian roulette
Simon Friend, Global Pharmaceutical Leader of PricewaterhouseCoopers, outlines the opportunities and challenges faced by companies entering the Russian pharmaceutical market

Which way now?
Beyond reproach: is independent assessment the only way forward for clinical trials? Peter Mansell explores

A CRO evolution or revolution?
Mark Greener asks whether CROs can continue to identify new areas for innovation? Or has it all been done before?

Poles apart
Mark Greener finds marketers are from Mars and scientists are from Venus